BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

876 related articles for article (PubMed ID: 29384212)

  • 1. Increased N6-methyladenosine causes infertility is associated with FTO expression.
    Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
    J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased
    Luo Q; Gao Y; Zhang L; Rao J; Guo Y; Huang Z; Li J
    Biomed Res Int; 2020; 2020():5735279. PubMed ID: 32884942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
    Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
    Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m
    Onalan E; Yakar B; Onalan EE; Karakulak K; Kaymaz T; Donder E
    J Coll Physicians Surg Pak; 2022 Sep; 32(9):1143-1148. PubMed ID: 36089710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway.
    Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W
    J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging.
    Jiang ZX; Wang YN; Li ZY; Dai ZH; He Y; Chu K; Gu JY; Ji YX; Sun NX; Yang F; Li W
    Cell Death Dis; 2021 Jul; 12(8):744. PubMed ID: 34315853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct RNA
    Toh JDW; Crossley SWM; Bruemmer KJ; Ge EJ; He D; Iovan DA; Chang CJ
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25284-25292. PubMed ID: 32989163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of substrate recognition and N6-methyladenosine demethylation revealed by crystal structures of ALKBH5-RNA complexes.
    Kaur S; Tam NY; McDonough MA; Schofield CJ; Aik WS
    Nucleic Acids Res; 2022 Apr; 50(7):4148-4160. PubMed ID: 35333330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased N(6)-methyladenosine in peripheral blood RNA from diabetic patients is associated with FTO expression rather than ALKBH5.
    Shen F; Huang W; Huang JT; Xiong J; Yang Y; Wu K; Jia GF; Chen J; Feng YQ; Yuan BF; Liu SM
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E148-54. PubMed ID: 25303482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2.
    Zhou L; Han X; Li W; Wang N; Yao L; Zhao Y; Zhang L
    Reprod Sci; 2022 Apr; 29(4):1305-1315. PubMed ID: 34254281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Level of N6-Methyladenosine in Peripheral Blood RNA: A Novel Predictive Biomarker for Gastric Cancer.
    Ge L; Zhang N; Chen Z; Song J; Wu Y; Li Z; Chen F; Wu J; Li D; Li J; Wang C; Wang H; Wang J
    Clin Chem; 2020 Feb; 66(2):342-351. PubMed ID: 32040577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3 and ALKBH5 oppositely regulate m
    Song H; Feng X; Zhang H; Luo Y; Huang J; Lin M; Jin J; Ding X; Wu S; Huang H; Yu T; Zhang M; Hong H; Yao S; Zhao Y; Zhang Z
    Autophagy; 2019 Aug; 15(8):1419-1437. PubMed ID: 30870073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m
    Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K
    Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N(6)-Methyladenosine: a conformational marker that regulates the substrate specificity of human demethylases FTO and ALKBH5.
    Zou S; Toh JD; Wong KH; Gao YG; Hong W; Woon EC
    Sci Rep; 2016 May; 6():25677. PubMed ID: 27156733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTO-Dependent N
    Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
    Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose Is Involved in the Dynamic Regulation of m6A in Patients With Type 2 Diabetes.
    Yang Y; Shen F; Huang W; Qin S; Huang JT; Sergi C; Yuan BF; Liu SM
    J Clin Endocrinol Metab; 2019 Mar; 104(3):665-673. PubMed ID: 30137347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic m6A modification regulates local translation of mRNA in axons.
    Yu J; Chen M; Huang H; Zhu J; Song H; Zhu J; Park J; Ji SJ
    Nucleic Acids Res; 2018 Feb; 46(3):1412-1423. PubMed ID: 29186567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue.
    Nakagawa N; Tanaka K; Sonohara F; Kandimalla R; Sunagawa Y; Inokawa Y; Takami H; Hayashi M; Yamada S; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
    Anticancer Res; 2020 Dec; 40(12):6665-6676. PubMed ID: 33288560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of m6A demethylase (ALKBH5, FTO) genetic polymorphism and expression levels on the development of pulmonary tuberculosis.
    Zhang TP; Li R; Wang LJ; Li HM
    Front Cell Infect Microbiol; 2022; 12():1074380. PubMed ID: 36619747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m6A Regulators in Human Adipose Tissue - Depot-Specificity and Correlation With Obesity.
    Rønningen T; Dahl MB; Valderhaug TG; Cayir A; Keller M; Tönjes A; Blüher M; Böttcher Y
    Front Endocrinol (Lausanne); 2021; 12():778875. PubMed ID: 34950106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.